PerkinElmer Appoints Vice President, Business Development
News Jan 20, 2006
PerkinElmer, Inc. has announced the appointment of Dr. Aaron Geist as Vice President, Business Development for the Company.
Dr. Geist will be responsible for developing PerkinElmer's strategic partnerships and acquisition opportunities.
Geist joins PerkinElmer from Robert W. Baird where he served as Director and Senior Research Analyst.
In this role, he was responsible for generating investor research on 22 life sciences, medical diagnostics and medical device companies, and was chosen as a top analyst by both The Wall Street Journal and Forbes/StarMine in 2004. He previously worked in medical research with a specialization in infectious diseases.
Aaron holds a Ph.D. in microbiology and molecular virology from Thomas Jefferson University in Philadelphia, Pennsylvania, and bachelor of science degrees in genetics and biology from the University of Western Ontario in Canada.
"Aaron brings exceptional domain knowledge, market understanding and business acumen to his new role," said Robert F. Friel, Vice Chairman of PerkinElmer, Inc.
"We look forward to his leadership in developing and growing the PerkinElmer business portfolio, particularly in the areas of molecular medicine, genetic screening and medical imaging."
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.READ MORE